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Abstract
Background: Many mammalian genes are organized as bidirectional (head-to-head) gene pairs
with the two genes separated only by less than 1 kb. The transcriptional regulation of these
bidirectional gene pairs remains largely unclear, but a few studies have suggested that the two
closely adjacent genes in divergent orientation can be co-regulated by a single transcription factor
binding to a specific regulatory fragment. Here we report an evolutionarily conserved bidirectional
gene pair, known as the PREPL-C2ORF34 gene pair, whose transcription relies on the synergic
cooperation of two transcription factors binding to an intergenic bidirectional minimal promoter.
Results:  While  PREPL  is present primarily in brain and heart, C2ORF34  is ubiquitously and
abundantly expressed in almost all tissues. Genomic analyses revealed that these two non-
homologous genes are adjacent in a head-to-head configuration on human chromosome 2p21 and
separated by only 405 bp. Within this short intergenic region, a 243-bp GC-rich segment was
demonstrated to function as a bidirectional minimal promoter to initiate the transcription of both
flanking genes. Two key transcription factors, NRF-2 and YY-1, were further identified to
coordinately participate in driving both gene expressions in an additive manner. The functional
cooperation between these two transcription factors, along with their genomic binding sites and
some cis-acting repressive elements, are essential for the transcriptional activation and tissue
distribution of the PREPL-C2ORF34 bidirectional gene pair.
Conclusion: This study provides new insights into the complex transcriptional mechanism of a
mammalian head-to-head gene pair which requires cooperative binding of multiple transcription
factors to a bidirectional minimal promoter of the shared intergenic region.
Background
In prokaryotic genomes, genes within operons usually
have much shorter intergenic distances than genes at the
borders of transcription units [1,2]. The distinct organiza-
tion of operonic genes in near proximity is thought to
facilitate gene co-expression and co-regulation. Recent
evidence suggests that some eukaryotic genes also tend to
be in close physical vicinity. For example, in the genomes
of yeast, worm, and fly, a number of functionally related
genes were shown to be located one near another [3-7]. In
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mammals, as genes are more dispersed throughout the
genomes, the presence of two genes in immediate proxim-
ity of each other has long been regarded as a rare excep-
tion. Surprisingly, after the human and mouse genomes
were decoded, there are more than 10% of the genes
found to be arranged as bidirectional (head-to-head) gene
pairs with two genes separated only by a less than 1 kb of
genomic DNA [8-11]. Whilst some of these neighboring
genes have evolved from a common ancestral gene by
duplication, many are totally unrelated to each other and
encode proteins involved in diverse biochemical path-
ways in different compartments of cells and tissues
[10,12].
To date, the transcriptional regulation of mammalian
head-to-head gene pairs remains largely unknown, but a
few studies have suggested that the two closely adjacent
genes in divergent orientation can be co-regulated by a
single transcription factor binding to a specific promoter
region [13-17]. Known examples include the human Par-
kinson's disease-related PACRG-PARK2  gene pair, the
highly homologous mouse surfeit Surf1-Surf2 gene pair,
and the non-homologous mouse Sars2-Mrps12 gene pair,
in which the expression of two genes is delicately regu-
lated by a transcription factor: in these cases N-myc, YY-1,
and NF-Y, respectively [13-15]. In this report, we provide
evidence for the existence of an evolutionarily conserved
head-to-head gene pair, known as the PREPL-C2ORF34
gene pair, whose expression actually depends on the syn-
ergic cooperation of two transcription factors binding to a
critical bidirectional regulatory element within a short
intergenic region.
PREPL  (prolyl endopeptidase-like), formerly named as
KIAA0436 [18], is a member of the prolyloligopeptidase
family of serine proteases [19,20]. Sequence analysis and
secondary structure predictions revealed that this protease
is similar to oligopeptidase B which utilizes a serine
hydroxyl group to cleave target proteins. However, unlike
oligopeptidase B which preferentially cleaves after an
arginine or lysine residue, PREPL cannot cleave after any
basic residue of the substrates [20]. This suggests that the
function of PREPL may be different from that of oli-
gopeptidase B and other known prolyloligopeptidases
[20]. Clinical studies have demonstrated that chromo-
somal deletions involving the PREPL gene often lead to
autosomal recessive syndromes such as hypotonia, facial
dysmorphism, neonatal seizures and developmental
delay [21,22]. The severity of these syndromes is closely
related to the size of chromosomal deletion and the
number of genes involved. For instance, patients with a
relative mild HCS (hypotonia-cystinuria syndrome) are
missing both alleles of SLC3A1 (solute carrier family 3,
member 1) and PREPL on chromosome 2p21. In a more
severe, atypical HCS phenotype, an additional gene
C2ORF34  (chromosome 2 open reading frame 34) is
deleted, whereas in the most severe 2p21 deletion syn-
drome the open reading frame of PPM1B (protein phos-
phatase magnesium-dependent 1B) is seriously disrupted
[19,22-26]. Interestingly, among these four cluster genes
that are associated with autosomal recessive disorders,
only PREPL and C2ORF34 were found to lie immediately
adjacent to each other in a head-to-head configuration in
many species including human, mouse, rat, dog and
chicken. The evolutionarily conserved close proximity
and divergent orientation indicate that the two genes are
likely co-regulated by some shared intergenic regulatory
elements.
Herein, we determined that PREPL and C2ORF34 are sep-
arated by only a 405-bp intergenic DNA region in the
human genome. Within this small intergenic region, a
243-bp GC-rich segment was shown to function as a bidi-
rectional minimal promoter to initiate transcription of
both flanking genes. By performing a series of promoter
analyses, including chromatin immunoprecipitation and
electrophoretic mobility shift assays, two transcription
factors, NRF-2 and YY-1, were indentified to be involved
in the regulation of the bidirectional minimal promoter.
The functional cooperation between these two key tran-
scription factors, along with their genomic binding sites
and some cis-acting repressive elements, is essential for
the transcriptional regulation and tissue distribution of
the PREPL-C2ORF34 head-to-head gene pair.
Results
Tissue expression patterns of human PREPL and C2ORF34 
genes
In order to determine the presence and expression pat-
terns of the PREPL and C2ORF34 genes, we performed
Northern blot analysis on polyA+ RNA isolated from 12
different human tissues. As illustrated in Figure 1, while
the PREPL probe identified a band of ~5 kb present pre-
dominantly in brain and heart, hybridization of the same
array with the C2ORF34  probe revealed an abundant
band of ~2 kb detected in almost every tissue examined.
This suggests that the transcriptions of the PREPL  and
C2ORF34 genes in most tissues are likely to be differen-
tially controlled by some regulatory elements situated
within their 5'-upstream intergenic region.
Determination of the size of the intergenic region between 
human C2ORF34 and PREPL genes
Following characterization of tissue distribution patterns,
we attempted to pinpoint the precise transcriptional start
sites (TSSs) of the C2ORF34 and PREPL genes to ascertain
the length of their intergenic spacer. We first utilized exon-
specific primers to amplify genomic DNA fragments
encompassing the first exons of both genes. The PCR
products were then purified and sequenced to confirm
that these two genes are indeed arranged in a head-to-
head configuration on human chromosome 2p21 (FigureBMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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2). By performing 5'-RACE with fetal brain-derived cDNA
as a template, both genes were identified to contain mul-
tiple TSSs including two for C2ORF34 and three for PREPL
(Figure 2B). It should be noted that, during the course of
5'-RACE analysis, we unexpectedly detected a PREPL
splice variant which uses an alternative, 184-bp untrans-
lated exon 1 (denoted as exon 1a, see Figures 2, Figure 3,
and Additional File 1). With this newly found 5'-untrans-
lated exon, the shortest intergenic distance between the
closest TSSs for PREPL and C2ORF34 was calculated to be
405 bp (Figure 2). In order to facilitate our subsequent
analyses of the promoter activity of this 405-bp intergenic
region, here we denoted the positions of nucleotides with
respect to -1, the first intergenic nucleotide in front of the
PREPL transcriptional start site, and -405, the intergenic
nucleotide right before the transcriptional start site of
C2ORF34 (see Figure 2).
Interspecies comparison of the gene order, orientation and 
intergenic spacing of the PREPL and C2ORF34 genes
To investigate whether the close physical proximity and
head-to-head configuration of the PREPL and C2ORF34
genes are conserved throughout evolution, we compared
the chromosomal localization and transcriptional orien-
tation of both genes in different species including human,
mouse, rat, dog and chicken. The results revealed that not
only the gene order but also the compact head-to-head
arrangement are evolutionarily conserved (data not
shown). Even the size and nucleotide sequence of their
intergenic spacing were found to be conserved, with a
fragment of about 300 bp spanning from part of the exon
1 of C2ORF34  to the first two-thirds of the intergenic
region, showing an average GC content greater than 70%
(see Additional File 2). By aligning the human, mouse
and rat sequences of this well-conserved, GC-rich region,
several consensus transcription factor binding sites were
identified. On the basis of these findings, we then
attempted to analyze the possible role of these sites in
governing the expression of the PREPL-C2ORF34 bidirec-
tional gene pair.
Functional characterization of the asymmetric 
bidirectional promoter activity of the intergenic region
In order to identify the key elements responsible for the
transcriptional regulation of the PREPL-C2ORF34  gene
pair, a series of DNA fragments containing all or part of
the 405-bp intergenic region were cloned into the pro-
moterless pGL3-basic vector followed by luciferase activ-
ity assays. Due to the fact that the regulatory elements are
often situated within 300-bp upstream or downstream of
the TSSs [27,28], here we cloned a 1,053-bp fragment,
from position -718 to +335 (see Figure 3), consisting of
the entire intergenic region and approximately 300 bp
beyond its two boundaries, as the full-length promoter
construct. By measuring the luciferase activity in human
U87MG cells where both C2ORF34 and PREPL were ade-
quately expressed, this full-length -718/+335 construct
was shown to possess a promoter activity stronger than
the control SV40 in driving reporter gene expression in the
sense (relative to PREPL) orientation (Figure 3). Several
progressive deletions from the 5'-end of the full-length -
718/+335 construct were then generated in an attempt to
determine the minimal promoter region necessary to
drive PREPL gene transcription. As summarized in Figure
3, results from luciferase activity measurements pin-
pointed a 220-bp segment, from -445 to -226 spanning
the first 40 bp of C2ORF34 exon 1 to the 180-bp 5'-end of
the intergenic region, that is critical for the transcription of
the PREPL gene. Similar progressive deletions from the
full-length +335/-718 insert were also constructed to clar-
ify the promoter activity in the antisense (relative to
C2ORF34) direction. The luciferase assays demonstrated
that a 218-bp segment, from -203 to -419 spanning the 5'-
end 203-bp of the intergenic region and the first 14 bp of
C2ORF34 exon 1, is responsible for driving transcription
of the C2ORF34 gene (Figure 3).
Based on the above results, we then cloned a 243-bp frag-
ment (from position -445 to -203, see the first " " bar
in Figure 3) covering both the identified -445/-226 pro-
moter region for PREPL and the -203/-419 promoter region
for C2ORF34 in two opposite orientations and measured
its potential bidirectional promoter activity. To our sur-
prise, while no obvious difference was observed between
the assays driven by the 243-bp (-445/-203) fragment alone
or by the full-length (-718/+335) construct toward the
PREPL direction, the same 243-bp fragment but in opposite
¬®
Northern blot analysis of PREPL and C2ORF34 in various tis- sues Figure 1
Northern blot analysis of PREPL and C2ORF34 in vari-
ous tissues. Human 12 major tissue polyA+ RNA blot (Ori-
Gene) was hybridized with 32P-labeled PREPL (upper panel), 
C2ORF34 (middle panel) and control ACTB (b-actin; lower 
panel) cDNA probes. Note that the commercial ACTB probe 
can recognize non-muscle b-actin (upper band) as well as 
smaller size a- or g-actin isoform (lower band) found in cer-
tain tissues such as heart and muscle.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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orientation (-203/-445) was able to significantly increase
the luciferase activity in the C2ORF34 direction by at least
12-fold as compared to the -203/-718 or the control +335/
-718 full-length insert (Figure 3). Furthermore, removal of
the sequence of the 243-bp fragment either from the 5'- or
3'-end (see the last three " " bars in Figure 3) all
resulted in a decrease of the luciferase activities in both
directions. Together these findings suggest that the 243-bp
fragment is likely to function as a bidirectional minimal
promoter, and that the region from position -446 to -718
may serve as a repressive element to suppress the transcrip-
tion activity of the C2ORF34 gene.
To further confirm the functional significance of the iden-
tified 243-bp regulatory element, we determined the effect
of its promoter strength on the expressions of the two
flanking genes. The results, similar to those obtained by
the aforementioned Northern blot analyses (Figure 1),
revealed that the levels of C2ORF34 transcripts remained
constant in various cell lines whereas PREPL was found to
be expressed in brain H4 and U87MG cells but much less
in lung WI38 and IMR90 cells (Figure 4). In accordance
with this, although no notable difference was observed in
the relative luciferase activity driven by the 243-bp (-445/
-203) fragment toward the C2ORF34 direction, the rela-
tive luciferase activity of the same fragment toward the
opposite PREPL direction was shown to be more elevated
¬®
Determination of the size and sequence of the intergenic region between human C2ORF34 and PREPL genes Figure 2
Determination of the size and sequence of the intergenic region between human C2ORF34 and PREPL genes. 
A) The first few exons of C2ORF34 (black boxes) and PREPL (grey boxes), the introns, and the shared intergenic segment (mid-
dle white bar) are shown. Bent arrows represent the gene directions and transcriptional start sites (TSSs) identified by 5'-
RACE. The shortest intergenic distance between the two genes is calculated to be 405 bp and numbered (from -1 to -405) 
from the telomeric (tel) to the centromeric (cen) end. B) The 5'-RACE products, which were sequenced from the shared 
intergenic region to the direction of downstream gene transcription, revealed multiple TSSs (marked with an asterisk) including 
two for C2ORF34 and three for PREPL. C) The bent arrows and the bold C and G nucleotides denote the different TSSs for 
C2ORF34 and PREPL, respectively. The 405-bp intergenic region is boxed.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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in brain than in lung cells (Figure 4). These results indi-
cate that the 243-bp minimal promoter element is likely
responsible for directing differential expression of the
PREPL  gene, if not also for the neighboring C2ORF34
gene.
It has previously been proposed that, in addition to the
bidirectional minimal promoter, DNA methylation may
also be participated in the transcriptional regulation of
bidirectional gene pairs [29,30]. By using Methprimer
software http://www.urogene.org/methprimer and a
modified criteria [31], which defined the size of a CpG
island as larger than 200 bp and the ratio of observed ver-
sus expected CpGs as greater than 0.7, we identified a GC-
rich fragment spanning from part of the exon 1 of
C2ORF34 to the first two-thirds of the 405-bp intergenic
region (see Additional File 2). To elucidate whether the
differential expression of C2ORF34 and PREPL is contrib-
uted by DNA methylation, we measured the methylation
status of each individual CpG site. The assay results dis-
played no notable differences in the CpG methylation
patterns of various normal tissues (Additional File 2). This
indicates that the tissue-specific pattern of both C2ORF34
and PREPL genes may not be controlled directly by DNA
methylation, but rather be regulated by some transcrip-
tional factors binding to the identified 243-bp bidirec-
tional minimal promoter.
Identification of transcription factor binding sites in the 
bidirectional minimal promoter
Sequence comparison revealed that the 243-bp bidirec-
tional minimal promoter is evolutionarily conserved
among distant organisms. As illustrated in Figure 5,
although neither TATA-box nor CCAAT element were
Determination of the promoter activity of the intergenic region Figure 3
Determination of the promoter activity of the intergenic region. The directions of gene transcription are indicated by 
arrows. Here, a 1053-bp fragment (from position -718 to +335) consisting of the entire 405-bp intergenic region and ~300 bp 
beyond its two boundaries is cloned as the full-length promoter construct. Progressive deletions from this full-length promoter 
construct were produced and inserted into the promoterless vector in either the sense (relative to PREPL) or antisense (rela-
tive to C2ORF34) direction. The resulting luciferase activity of transiently transfected U87MG cells is given adjacent to each 
construct. Co-transfection of pRL-TK plasmid was performed for normalization of transfection efficiencies and cell viability. 
Units are relative to SV40 control promoter, defined as 1×. The experiments were performed in triplicate. Data are represent-
ative of three independent experiments, and error bars are ± standard deviation. A similar result was also observed in human 
H4 cells (data not shown).BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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found in this intergenic region, several potential transcrip-
tion factor binding sites were recognized in silico by Mat-
Inspector http://www.genomatix.de/products/
MatInspector and MOTIF http://motif.genome.jp soft-
wares. These potential binding sites include two for TFAP-
4 (denoted as TFAP-4(A), at nt -407 to -400; and TFAP-
4(B), at nt -264 to -255), one for MZF-1 (at nt -398 to -
391), one for USF (at nt -362 to -353), two for NRF-2
(denoted as NRF-2(A) at nt -307 to -298; and NRF-2(B) at
nt -299 to -290) and one for YY-1 (at nt -232 to -215).
Among these putative binding sequences, some core bind-
ing sites and their flanking segments such as those for
USF, NRF-2, and YY-1 were found to be evolutionarily
more conserved than other transcription factor binding
sites (Figure 5). In particular, as the USF-binding sequence
is known to be one of the most frequently predicted
motifs in many gene promoters, here we chose to first
examine the possible role of NRF-2 and YY-1 in the activa-
tion of C2ORF34 and PREPL transcriptions. The luciferase
assays performed in U87MG cells showed that point
mutations at the NRF-2(A) site (termed as -203/-
445mu_NRF-2(A)  and -445/-203mu_NRF-2(A)) had no major
effect on the promoter activity in either direction (Figure
6). However, mutations occurring at the NRF-2(B) bind-
ing site (denoted as -203/-445mu_NRF-2(B)  and -445/-
203mu_NRF-2(B)) caused a significant reduction of the luci-
ferase activity as compared to that of the control 243-bp
bidirectional minimal promoter (~74% decrease in the
C2ORF34  direction and ~58% decrease in the PREPL
direction, see Figure 6). These results indicate that the sec-
ond NRF-2 binding sequence (from position -299 to -
290) is essential for the activation of the PREPL-C2ORF34
bidirectional gene pair. Moreover, mutant constructs at
the YY-1 site (named as -203/-445mu_YY-1  and -445/-
203mu_YY-1) displayed a drastically reduced promoter
activity toward the PREPL direction (~86% decrease rela-
tive to that of the control 243-bp segment) but a less
severe reduction in the C2ORF34 direction (with only a
~37% decrease relative to that of the minimal promoter).
This implies that the YY-1 site is more important than the
NRF-2(B) site for PREPL expression. The same data also
conclude that the NRF-2(B) binding site is functionally
more critical than the YY-1 site in driving C2ORF34 tran-
scription, as evident from mutations at the NRF-2(B) site
resulting in a much decreased reporter gene activity
toward the C2ORF34 direction (Figure 6). More signifi-
cantly, double mutations at the NRF-2(B) and the YY-1
binding sites (denoted as -445/-203mu_NRF-2(B)/YY-1 and -
203/-445mu_NRF-2(B)/YY-1) further decreased the promoter
activity to the basal level in both directions (Figure 6).
Similar results were also observed in other cell lines
including brain H4, GBM8401, and GBM8901 cell lines
(Additional File 3). Together these findings provide the
first strong evidence that, in addition to their individual
effects on the full activity of the bidirectional minimal
promoter region, the NRF-2 and YY-1 transcription factors
may coordinately participate in driving both gene expres-
sions in an additive manner.
Characterization of the specific NRF-2 and YY-1 
transcription factors binding to the bidirectional promoter 
by EMSA
After we assessed the regulatory importance of the NRF-2
and YY-1 binding sites within the intergenic region, the
EMSA was performed to study the protein-binding to such
sites. As shown in Figure 7, by incubating cell nuclear pro-
Effect of promoter strength of the 243-bp regulatory element on the expressions of C2ORF34 and PREPL genes Figure 4
Effect of promoter strength of the 243-bp regulatory element on the expressions of C2ORF34 and PREPL 
genes. A) Semi-quantitative RT-PCR analysis of C2ORF34, PREPL, and control ACTB transcripts. RNAs used in this analysis 
were obtained from human brain (H4 and U87MG) and lung (WI38 and IMR90) cells. The specific primers for each gene are 
indicated in the methods. B) The relative luciferase activities driven by the 243-bp (-445/-203) fragment toward either the 
C2ORF34 or PREPL direction in different cells were determined. The transfection efficiency and cell viability were normalized 
with the pRL-TK plasmid. Units are relative to the luciferase activity driven by the 243-bp bidirectional minimal promoter in 
C2ORF34 direction, defined as 100%. The experiments were performed in triplicate and repeated independently at least twice. 
The error bars are ± standard deviation.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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Multiple sequence alignment of the bidirectional minimal promoter region of the PREPL-C2ORF34 gene pair Figure 5
Multiple sequence alignment of the bidirectional minimal promoter region of the PREPL-C2ORF34 gene pair. 
The identified 243-bp bidirectional minimal promoter region on human chromosome 2p21 spans from the first 40-bp (position 
-445 to -406) of C2ORF34 exon 1 to the first half (position -405 to -203) of the intergenic region. All putative transcription fac-
tor binding sites found in this bidirectional promoter are indicated above the alignment. The core sequence of each transcrip-
tion factor target site is highlighted in black, with the bent arrows representing two C2ORF34 TSSs.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
Page 8 of 18
(page number not for citation purposes)
tein extracts with the -311/-282 probe that contained two
NRF-2 binding sites, three major shifted bands were
detected (Figure 7, lane 2). These band-shifts were
sequence-specific as addition of an excess of unlabeled
wild-type probe could compete out the binding (Figure 7,
lanes 3 and 4). Interestingly, while competitors contain-
ing mutated NRF-2(B) site failed to affect the binding of
nuclear proteins to hot probe (Figure 7, lanes 5 and 6), a
strong competitive effect was obtained with the use of a
10-fold excess of cold probe with mutation at the NRF-
2(A) site (Figure 7, lane 8). These results again indicate
that NRF-2(B), the second NRF-2 binding sequence from
position -299 to -290, is more important than NRF-2(A)
in regulating the transcription of the PREPL-C2ORF34
bidirectional gene pair. To more clarify the specific bind-
ing of NRF-2 and YY-1 to the bidirectional promoter, the
nuclear extracts were incubated with antibodies against
NRF-2, YY-1, and NF-1 to examine the inhibition and/or
supershift of the protein/DNA complex. As revealed in
Figure 8, by incubating nuclear protein extracts either with
the same -311/-282 probe or with the -290/-204 probe
which contained the sole YY-1 binding site, several
retarded bands were detected (Figure 8, lanes 1 and 7).
Such a binding activity with the -311/-282 probe or -290/
-204 probe could be significantly competed with 1- or 10-
fold molar excess of unlabeled oligonucleotide (self-com-
petition; Figure 8, lanes 2–3 and 8–9). Furthermore, when
EMSA was performed in the presence of specific anti-NRF-
2 or anti-YY-1 antibodies, a supershifted band was
observed in each case (Figure 8, lanes 4 and 11). In both
cases no supershift was observed with the negative control
anti-NF-1 antibody (Figure 8, lanes 6 and 12). These
results suggest that the two identified binding sites are
indeed associated with sequence-specific binding of NRF-
2 and YY-1 transcription factors present in the cell nuclear
extracts.
In vivo occupancy of the bidirectional minimal promoter 
by endogenous NRF-2 and YY-1 transcription factors
To further verify whether NRF-2 and YY-1 are actually
bound to the bidirectional minimal promoter of the
PREPL-C2ORF34 gene pair in vivo, chromatin immuno-
precipitations (ChIPs) were performed in U87MG cells
using antibodies specific for NRF-2 and YY-1. As a nega-
tive control, another immunoprecipitation from the same
stock was carried out using anti-IgG antibody. The regions
Identification of the functional significance of the NRF-2 and YY-1 binding sites in the bidirectional minimal promoter Figure 6
Identification of the functional significance of the NRF-2 and YY-1 binding sites in the bidirectional minimal 
promoter. Mutations at the first NRF-2 binding site are shown as a filled circle and denoted as -203/-445mu_NRF-2(A) in the anti-
sense (relative to C2ORF34) and as -445/-203mu_NRF-2(A) in the sense (relative to PREPL) directions. Mutations at the second 
NRF-2 binding site are shown as a filled square and named as -203/-445mu_NRF-2(B) in the antisense and as -445/-203mu_NRF-2(B) in 
the sense directions. Mutations at the YY-1 binding site are shown as a filled triangle and termed as -203/-445mu_YY-1 and -445/
-203mu_YY-1 in two different directions. Double mutations at both the NRF-2(B) and the YY-1 binding sites are denoted as -445/
-203mu_NRF-2(B)/YY-1 and -203/-445mu_NRF-2(B)/YY-1. Units are relative to the wild-type bidirectional minimal promoter, defined as 
100%. The experiments were performed in triplicate. Data are representative of three independent experiments, and error 
bars are ± standard deviation.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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Assessment of the effect of NRF-2 binding elements on the formation of protein/DNA complex Figure 7
Assessment of the effect of NRF-2 binding elements on the formation of protein/DNA complex. The EMSA anal-
ysis was conducted as described in the Methods section. The double-stranded oligonucleotide probe (-311/-282) encompassing 
both NRF-2(A) and NRF-2(B) binding sites is shown on top. The arrow indicates free probe, and the arrowheads indicate three 
shifted bands found in the bottom panel. Lane 1 represents the biotin-labeled probe alone. Lane 2 represents the hot probe 
incubated with nuclear extracts. Lanes 3 and 4 represent the hot probe incubated with nuclear extracts in the presence of 
either 1- or 10-fold molar excess of cold wild-type probe, respectively. Lanes 5 and 6 represent the hot probe incubated with 
nuclear extracts in the presence of either 1- or 10-fold molar excess of unlabelled probe with mutation at the NRF-2(B) site, 
respectively. Lanes 7 and 8 are the same as lanes 5 and 6 except a cold probe with mutation at the NRF-2(A) site was used.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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Identification of NRF-2 and YY-1 binding specificities to the bidirectional minimal promoter Figure 8
Identification of NRF-2 and YY-1 binding specificities to the bidirectional minimal promoter. The probe (-311/-
282) which includes NRF-2 binding sites and the probe (-290/-204) which contains the sole YY-1 binding site are shown on top. 
Lanes 1 and 7 represent each probe incubated with nuclear extracts alone. Lanes 2 and 8 represent each probe incubated with 
a 1-fold molar excess of the cold competitor oligonucleotide. Lanes 3 and 9 represent each probe competed with a 10-fold 
molar excess of the unlabeled competitor oligonucleotide. Lanes 4 to 6 and 10 to 12 represent the same EMSA performed in 
the presence of three different antibodies: anti-NRF-2, anti-YY-1, and the negative control, anti-NF-1 antibody. The experi-
ments were repeated twice.BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
Page 11 of 18
(page number not for citation purposes)
surrounding the functional NRF-2 and YY-1 binding sites
were analyzed in parallel on immunoprecipitated chro-
matin. For PCR amplifications, a 1/10 dilution of input
chromatin was selected as a standard to indicate the effi-
ciency of the PCR reactions. As shown in Figure 9, while
nothing was detected with the use of the control anti-IgG
antibody, fragments from the bidirectional minimal pro-
moter of the intergenic region were able to be immuno-
precipitated by both anti-NRF-2 and anti-YY-1 antibodies
(Figure 9, lanes 4 and 8, respectively) in higher amounts
than the 1/10 input chromatin (Figure 9, lanes 2 and 6).
Similar results were also obtained from other ChIP assays
using additional cell lines such as brain H4, GBM8401
and GBM8901 cell lines (Additional File 4). Thus, it is
clear from these studies that NRF-2 and YY-1 are bound
specifically to the bidirectional minimal promoter of the
PREPL-C2ORF34 head-to-head gene pair in vivo.
Discussion
Bidirectional promoters have received considerable atten-
tion because of their capability to regulate the transcrip-
tion of two downstream genes [32]. They are commonly
present in prokaryotes and low eukaryotes but are consid-
ered to be rare in higher organisms. Recent genome
sequencing efforts, however, have revealed that a large
number of mammalian genes are in fact closely arranged
as divergent (head-to-head) gene pairs and separated only
by a less than 1 kb of intergenic spacer [[8,10,33]; and our
unpublished observations]. No definite explanation can
yet be given for the biological and evolutionary advan-
tages of this distinct type of divergent gene pairs. But the-
oretically, only when two genes are divergently organized
in close proximity (now referred more as "bidirectional
gene pairs") can be co-expressed and co-regulated by a
shared intergenic bidirectional promoter [11,34]. This
statement is supported by a recent study of whole-genome
microarray data showing that, in a given cell, approxi-
mately 68% of divergent genes are transcribed, compared
with 44% of all human genes [32]. It seems likely that the
presence of bidirectional promoters in mammalian
genomes is to facilitate functional co-regulation of two
adjacent genes, thus making bidirectional gene pairs more
favored by natural selection than any other gene organiza-
tion. By analyzing and comparing the intergenic
sequences of bidirectional gene pairs in different species,
it has been shown that the majority of intergenic regions
lack TATA and CCAAT boxes but are rich in GC content
[35-42]. Those findings are consistent with our character-
ization of the PREPL-C2ORF34 bidirectional gene pair, in
that neither a TATA box nor a CCAAT element could be
found within the identified 405-bp intergenic region (Fig-
ure 5). A CpG-rich island was indeed recognized, but its
methylation status does not seem to play an important
role in regulating the expression levels of the two down-
stream genes (see Additional File 2). It was also reported
that the intergenic regions found in mammalian genomes
often display a mirror sequence composition, such that
the Gs and Ts dominate on one side of the midpoint
whilst Cs and As dominate on the other side [43]. In the
case of the PREPL-C2ORF34 bidirectional gene pair pre-
sented in this work, however, no such a composition was
observed.
It is of interest to note that the PREPL-C2ORF34 gene pair
has several features in common with some other human
bidirectional gene pairs such as the Parkinson's disease-
related PACRG-PARK2 gene pair at 6q25.2–27, and the
brain-disease related PDCD10-SERPINI1  gene pair at
3q26 [44,45]. In all three cases, the paired genes are non-
homologous to each other. PREPL, like PARK2  and
SERPINI1, has its tissue specificity and is present mainly
in brain and/or heart; where as C2ORF34, like PACRG and
Semi-quantitative PCR products from DNA prepared by ChIP assays Figure 9
Semi-quantitative PCR products from DNA prepared by ChIP assays. Lanes 1 and 5: No DNA control. Lanes 2 and 
6: The Input lanes correspond to PCR products derived from a 1/10 dilution of chromatin prior to immunoprecipitation. Lanes 
3 and 7: The IgG lanes correspond to PCRs containing chromatin immunoprecipitated with antibodies against control IgG. 
Lanes 4 and 8: The NRF-2a and YY-1 lanes correspond to PCRs containing chromatin immunoprecipitated with antibodies 
against NRF-2a and YY-1, respectively. All the amplified products represent a 254-bp region (from position -66 to -319) con-
taining both the NRF-2 and YY-1 binding sites of the PREPL-C2ORF34 bidirectional gene pair. Additional ChIP assays were per-
formed in other cell lines with similar results (presented in Additional File 4).BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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PDCD10, is expressed like a housekeeping gene in all tis-
sues (Figure 1). More significantly, the genetic variations
found in these genes are often correlated with brain or
genetic abnormalities. This implies that brain, being the
most complex and metabolically active organ in the body,
may utilize various bidirectional promoters to direct gene
expressions and cellular functions in a more efficient and
comprehensive manner.
C2ORF34 and PREPL are known to lie immediately adja-
cent to each other not only in humans but also in many
other species. Their evolutionarily conserved gene config-
uration and close proximity indicate that both genes need
to be tightly paired and may thus be co-regulated by some
common transcriptional regulatory elements. By generat-
ing a series of partial deletion constructs using firefly luci-
ferase as the reporter gene, we first identified a 273-bp
GC-rich segment, from position -446 to -718, which may
serve as a repressive element to suppress in particular the
transcriptional activity of the C2ORF34 gene. This repres-
sive effect is most likely due to some yet unidentified tran-
scriptional repressor, or may be caused by subsequent
disturbance of the chromatin structure within this GC-
rich DNA region. Results from luciferase activity assays
further suggest that the essential promoter activity is car-
ried within a 243-bp (from position -445 to -203)
genomic region, and that two transcription factors, NRF-2
and YY-1, can bind onto this critical bidirectional mini-
mal promoter to regulate the expression of both C2ORF34
and PREPL genes (Figure 3, 6, 7, 8). It should be noted
that the nucleotide sequence of the -718/-446 segment
revealed no ATG motifs that may interfere with the down-
stream luciferase gene expression at the level of transla-
tion. Nonetheless, we need to point out that although
highly unlikely, we cannot completely rule out the possi-
bility that RNA splice sites may have bypassed the ATG of
the luciferase reporter in our analysis.
NRF-2, also termed as GA-binding protein or GABP, has
long been known to act as a key nuclear activator in the
regulation of many mitochondrial-related genes [46].
Similar to a previous study on the promoter region of the
outer mitochondrial membrane translocase TOMM20
gene [47], in our identified 405-bp intergenic fragment
only one of the two putative NRF-2 binding sites was
found responsible for driving the bidirectional promoter
activity. More significantly, NRF-2 itself is also arranged as
a bidirectional gene pair with its adjacent ATP5J (an ATP
synthase coupling factor) gene on human chromosome
21. By binding to its 5'-intergenic region shared with the
ATP5J gene, NRF-2 is able to auto-regulate its own gene
transcription and subsequently affect the expression levels






















*All construct names refer to the positions of nucleotides, counting from the first to the last nucleotide of the inserted genomic DNA sequences. 
The inserted fragments were first amplified by PCR using a series of forward primers with a BglII site (5'-AGATCT) and reversed primers with a 
HindIII site (5'-AAGCTT). Each amplified fragment was then digested with two restriction enzymes and cloned into the pGL3-Basic vector 
(Promega).BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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of downstream mitochondrial-related genes [48]. In the
case of the PREPL-C2ORF34 gene pair, because NRF-2 is
shown to be more important in driving C2ORF34 expres-
sion and because patients with the 2p21 deletion syn-
dromes (in particular those occurring at C2ORF34) often
exhibit a unique mitochondrial dysfunction [19,22], we
speculate that the ubiquitously expressed C2ORF34 gene
may possess some cellular functions related to mitochon-
drial metabolisms and be ultimately regulated by NRF-2
along with the collaboration of YY-1 transcription factor.
Previously, YY-1 had been reported to serve as a necessary
and sufficient activator for the expression of some bidirec-
tional gene pairs [13,49]. As for the evolutionarily con-
served PREPL-C2ORF34 gene pair, mutations occurring at
the YY-1 binding site were shown to cause significantly
decreased promoter activity toward the PREPL direction
(Figure 6). This suggests that YY-1 is functionally more
important than NRF-2 in driving PREPL  transcription.
Moreover, because the dual activator/repressor role of YY-
1 is often related to its cellular concentration as well as its
ability to interact with other cofactors [50-52], here we
propose that YY-1 can directly bind to the bidirectional
minimal promoter of the PREPL-C2ORF34 gene pair and,
depending on the intracellular concentrations of YY-1 and
its interacting cofactors such as NRF-2, serve as both a pos-
itive regulator and a negative regulator in determining the
tissue distribution pattern of the PREPL  gene. Finally,
double mutations at both the NRF-2 and YY-1 binding
sites completely abolished the activity of the bidirectional
minimal promoter in both directions (Figure 6). This
implies that, in addition to their individual effect on the
full activity of the bidirectional minimal promoter region,
NRF-2 and YY-1 coordinately participate in driving both
C2ORF34  and  PREPL  gene expressions in an additive
manner. The functional cooperation between these two
transcription factors, along with their binding efficacy to
the asymmetric bidirectional minimal promoter and
some cis-acting repressive elements, is essential for the
transcriptional activation and tissue distribution of the
PREPL-C2ORF34 head-to-head gene pair.
Conclusion
Unlike previous reports suggesting that two adjacent
genes in a head-to-head configuration can be co-regulated
by a single transcription factor binding to a specific pro-
moter segment, here we demonstrated that the expression
of the disease-related PREPL-C2ORF34 bidirectional gene
pair is in fact dependent on the synergic cooperation of
two transcription factors interacting with a 405-bp inter-
genic DNA region. Although PREPL is present primarily in
brain and heart, C2ORF34  is ubiquitously and abun-
dantly expressed in almost all tissues examined. Their dis-
tinct expression patterns may not be directly regulated by
DNA methylation but rather be controlled by the coordi-
nated binding of NRF-2 and YY-1 onto a 243-bp asym-
metric bidirectional minimal promoter. An additional
GC-rich region, from nt -446 to nt -718, is likely to serve
as a repressive element suppressing the transcription activ-
ity of the C2ORF34 gene. Finally, various analyses includ-
ing luciferase activity experiments, electrophoretic
mobility shift assays and in vivo chromatin immunopre-
cipitation verified the direct binding of NRF-2 and YY-1
onto the shared intergenic region, thus confirming that
these two transcription factors function coordinately with
the bidirectional minimal promoter to regulate the tran-
scriptions of both PREPL and C2ORF34 genes.
Methods
Cell cultures
All culture media were purchased from Gibco Invitrogen
(Carlsbad, CA, USA). Human neuroglioma U87MG,
glioblastoma GBM8401 and GBM8901, and lung fibrob-
last IMR90 and WI38 cells were obtained from the Amer-
ican Type Culture Collection (ATCC, Manassas, VA, USA)
and grown in Minimum Essential Medium Eagle (MEM-E,
high glucose with L-glutamine and phenol red) supple-
mented with 10% fetal bovine serum (FBS) and pyruvate
(HyClone, Logan, UT, USA). Human neuroblastoma H4
cells were also purchased from ATCC but cultured in Dul-
becco's Modified Eagle Medium (D-MEM) supplemented
with 10% FBS and 0.1 mM non-essential amino acids
(Biological Industries, Kibbutz Beit Haemek, Israel). All
cell lines were maintained at 37°C in a humidified atmos-
phere of 5% CO2 in air.
Northern blot analysis
Human 12 major tissue polyA+ blot (HB-2010) was pur-
chased from OriGene (Rockville, MD, USA). To increase
the probe specificity and sensitivity in the recognition of
all possible splicing variants, a 735-bp probe spanning
from exon 9 to exon 14 of the PREPL gene was amplified
from FirstChoice PCR-Ready human brain cDNA
(Ambion, Austin, TX, USA) using the forward primer 5'-
ATGGATTTGAAAATGAATTTCAGG-3' and the reverse
primer 5'-TCAGAATTTCAGGTATTTCTTAAGA-3'. Another
498-bp probe, spanning from exon 1 to exon 6 of the
C2ORF34 gene, was amplified from the same cDNA using
the forward primer 5'-ATGGAGTCGCGAGTCGCG-
GACGCTG-3' and the reverse primer 5'-AGCAACCAT-
GAGCCCAGCCAAGCA-3'. All the PCRs were performed
on T3 thermocycler (Whatman Biometra, Goettingen,
Germany) using Ex Taq polymerase (Takara, Otsu, Singa,
Japan) under the following condition: 1 cycle of 95°C for
10 min; 30 cycles of 95°C for 30 sec, 60°C for 30 sec, and
72°C for 40 sec; and 1 cycle of 72°C for 10 min. All
amplified PCR products were visualized on agarose gels
and confirmed by autosequencing on an ABI PRISM 3700
automated sequencer (Applied Biosystems, Foster City,
CA, USA) by the core facility of the National HealthBMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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Research Institutes (Zhunan, Taiwan). The sequence-veri-
fied probes, along with the internal control b-actin
(ACTB) probe supplied by the manufacturer (OriGene),
were labeled with [32P]dCTP by random prime labeling
system (Amersham/GE Healthcare, Piscataway, NJ, USA).
Pre-hybridization and hybridization of the membrane
was performed in ULTRAhyb solution (Ambion) at 42°C.
The hybridized membrane was washed twice with 2× SSC
and 0.1% (w/v) SDS for 20 min at 42°C followed by
washed twice with 0.25× SSC and 0.1% (w/v) SDS (w/v)
for 20 min at 65°C. The hybridization signal was detected
by exposure to X-ray film (Eastman Kodak, Rochester, NY,
USA). The signal was stripped off and rehybridized with
ACTB as an internal control.
5'-Rapid amplification of cDNA ends (RACE)
The 5'-RACE analysis on the human fetal brain was carried
out by two consecutive PCR reactions with the use of First
Choice RNA ligase-mediated RACE kit (Ambion). In the
first round of PCR, at least five reverse primers were
attempted for each gene in a trial-and-error fashion until
successful PCR amplification occurred. In brief, the PCR
was performed using a forward 5'-RACE outer primer pro-
vided by the manufacturer and the most appropriated and
specific reverse primer for PREPL (5'-CAATCAATGAAG-
GGCTGGTCTAACT-3') or for C2ORF34  (5'-GGTCCA-
GAAACAGGCAGTCAGCACACATAACA-3') under the
following conditions: 1 cycle at 95°C for 5 min; 40 cycles
at 95°C for 1 min, 55°C for 1 min and 72°C for 1 min;
and 1 cycle at 72°C for 10 min. For the second round of
PCR, the DNA amplified during the first round of PCR
was diluted 1:100 and reamplified using a forward 5'-
RACE inner primer provided by the manufacturer with
either a reverse inner PREPL  primer (5'-CCAGTGAAG-
GCAGGCCGGAGAAC-3') or C2ORF34 primer (5'-GGTC-
CAGAAACAGGCAGTCAGCACACATAACA-3') under the
following conditions: 1 cycle at 95°C for 5 min; 40 cycles
at 95°C for 1 min, 57°C for 1 min and 72°C for 1 min;
and 1 cycle at 72°C for 10 min. The desired PCR products
were isolated from agarose gels and cloned into a pGEM-
T Easy vector (Promega, Madison, WI, USA) followed by
transformation into competent Top10 E. coli cells. Two to
three independent clones were then selected, purified,
and sequenced with generic sequencing primer to deter-
mine the 5'-ends of C2ORF34 and PREPL transcripts.
Interspecies comparison of the PREPL and C2ORF34 genes
The comparisons were performed based on the data
obtained from genome assemblies of the human NCBI
Build 36.2, the mouse NCBI Build 37.1, the rat RGSC 3.4,
the dog NCBI Build 2.1, and the chicken NCBI Build 2.1
databases http://www.ncbi.nlm.nih.gov. In brief, for all
the genes (i.e. C2ORF34, PREPL, SLC3A1  and PPM1B)
that were found to be clustered on human chromosome
2p21, at least three features were examined and compared
in each genome. These features included chromosomal
localization, orientation, and distance between the two
adjacent genes. All nucleotide sequences, in particular
those for C2ORF34 and PREPL, were downloaded from
the NCBI databases and aligned using Vector NTI software
(InforMax, Bethesda, MD, USA).
Bisulfite sequencing analysis of DNA methylation
Genomic DNAs used for bisulfate analysis were purchased
from Biochain (Biochain Institute, Hayward, CA, USA)
including samples of normal brain (Lot #A712158: male,
27-year old), normal colon (Lot #A80504: male, 23-year
old) and normal testis (Lot #A905081: male, 26-year old)
tissues. The CpG methylation status was analyzed using
the Zymo EZ DNA Methylation-Gold Kit (Zymo Research,
Orange, CA, USA) according the manufacturer's instruc-
tions. In brief, 1 mg of each genomic DNA was treated with
the CT Conversion reagent supplied within this kit under
the following conditions: 98°C for 10 min, 64°C for 4 h,
and then at 4°C until use. All bisulfite-converted DNA
samples were purified by the Zymo-Spin IC column with
600 ml M-Binding buffer, 100 ml M-Wash buffer, 200 ml M-
Desulphonation buffer, 200 ml M-Wash buffer, and then
eluted with 10 ml M-Elution buffer. The samples were then
PCR-amplified using the forward primer (5'-CCACAT-
AATTCCTCCTCTT-3') and reverse primer (5'-TCCA-
CATCTCTCTCATCCTCTTTTC-3') under following
condition: 1 cycle of 95°C for 10 min; 30 cycles of 95°C
for 30 sec, 50°C for 30 sec, and 72°C for 40 sec; and 1
cycle of 72°C for 10 min. The amplified products were
cloned into a pGEM-T Easy vector (Promega) followed by
transformation into competent Top10 E. coli cells. Four
individual clones for each tissue sample were randomly
selected and subjected to sequencing by the core facility of
the National Health Research Institutes.
Construction of reporter gene plasmids
All restriction enzymes were purchased from Takara. The
genomic DNA of peripheral blood lymphocytes was iso-
lated from a healthy donor using the QIAamp Blood kit
(Qiagen, Hilden, Germany) as described by the manufac-
turer. Various intergenic fragments between C2ORF34
and PREPL were amplified by PCR using ExTag polymer-
ase (TaKaRa) with a series of forward and reversed primers
(listed in Table 1) containing a BglII or HindIII cutting
site, respectively. Each amplified fragment was digested
with BglII and HindIII and then cloned into pGL3-Basic
vector (Promega) followed by autosequencing to ensure
no mutations had been introduced during the amplifica-
tion reaction. In order to facilitate subsequent characteri-
zation of the promoter activity of the intergenic region,
the positions of the most 5' exon of PREPL (exon 1a) or
C2ORF34 (exon 1) are numbered as +1 and -406, respec-
tively. Thus, the first intergenic nucleotide in front of the
PREPL transcriptional start site is numbered as -1, and theBMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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intergenic nucleotide right before the transcriptional start
site of C2ORF34 is numbered as -405.
Transient transfection and dual luciferase reporter assay
For luciferase reporter assays, the cells from different cell
lines were first seeded in 12-well culture plates at a density
of 1 × 105 cells per well and allowed to grow overnight.
Cells were then co-transfected, in triplicate, with 3 ml of
Lipofectamine 2000 (Gibco Invitrogen) and a mixture of
525 ng of DNA consisting of 500 ng of the tested pGL3
promoter constructs and 25 ng of the pRL-TK Renilla luci-
ferase reporter plasmid (Promega) in a serum-free
medium. The pGL3-promoter plasmid containing the
SV40 promoter was used as the positive control. After a 2-
h transfection at 37°C, the medium was replaced with
fresh culture medium supplemented with 10% FBS and
cells were incubated for another 24 h. After incubation,
cells were harvested and lysed in Passive Lysis Buffer
(Promega) at 4°C for 30 min. Cellular debris was
removed after centrifugation at 10,000 × g for 5 min at
4°C. The chemiluminescence of the two different luci-
ferases was measured using a SIRIUS luminometer
(Berthold, Bad Wildbad, Germany). The transfection effi-
ciency and cell viability were normalized with the pRL-TK
plasmid containing the Renilla luciferase gene under the
control of the TK promoter. Relative luciferase activity of
each clone was normalized to the pGL3-promoter vector
containing a firefly luciferase gene driven by the weak
SV40 promoter. The experiments were performed in trip-
licate and repeated independently at least three times.
Preparation of nuclear proteins from cultured cells
Nuclear extracts were prepared from cultured U87MG and
H4 cells using nuclear extraction kit (Panomics, Fremont
CA, USA) according to the manufacturer's specifications.
Cells grown to 80–90% confluence in 10 cm culture plates
were washed twice with an appropriate volume of ice-cold
PBS. After complete removal of PBS by centrifugation,
cells were treated with 1 mL of Buffer A working reagent
containing 1 mM DTT, 10 ml protease inhibitor, 10 ml
phosphatase inhibitor I, and 10 ml phosphatase inhibitor
II for 10 min at 4°C. Cells were released from the bottom
of the culture plate by using a sterile cell scraper and trans-
ferred into a 1.5 mL microcentrifuge tube with 14,000 × g
for 5 min at 4°C. The remnant pellet was re-suspended
with 100 ml Buffer B working reagent containing 1 mM
DTT, 1 ml protease inhibitor, 1 ml phosphatase inhibitor I,
and 1 ml phosphatase inhibitor II on ice for 60 min with
vortex every 10 min. Nuclear proteins were subsequently
obtained by centrifugation at 14,000 × g for 5 min at 4°C.
Electrophoretic Mobility Shift Assays (EMSA)
Electrophoretic mobility shift assays were performed by
using the EMSA gel shift kit (Panomics) according to the
manufacturer's instructions. In brief, the EMSA probe for
YY-1 binding assay was synthesized by PCR reaction using
the forward primer (5'-ACTCGCATCTCCTTGGCAAC-
CAGGG-3') and the reverse primer (5'-GGCCCTGGTT-
GCCAAGGAGATGCG-3') under the following
conditions: 1 cycle at 95°C for 5 min; 30 cycles at 95°C
for 30 sec, 68°C for 30 sec, and 72°C for 20 sec; and 1
cycle at 72°C for 10 min. The EMSA probe for NRF-2
binding analysis was synthesized with the forward primer
(5'-CCCGAATTCCGCATTTCCGGTACTCGCATC-3') and
the reverse primer (5'-GATGCGAGTACCGGAAATGCG-
GAATTCGGG-3') under the following conditions: 1 cycle
at 95°C for 5 min, 70°C for 30 sec, and 60°C for 30 sec.
With the same PCR condition, the mutant probe of NRF-
2(A) site was generated using the forward primer (5'-
CCCGAATTAAGCATTTCCGGTACTCGCATC-3') and the
reversed primer (5'-GATGCGAGTACCGGAAATGCT-
TAATTCGGG-3'), and the mutant probe of NRF-2(B) was
synthesized with forward primer (5'-CCCGAATTCCG-
CACTTAATGTACTCGCATC-3') and reversed primer (5'-
GATGCGAGTACATTAAGTGCGGAATTCGGG-3'). The
specific hot probes were prepared by labeling the same
oligonucleotide probes with biotin. The DNA-protein
binding reaction was performed in supplemented binding
buffer containing 1 ml of probe, 5 mg of nuclear extracts,
and 1 ml poly(dI-dC) at 15°C for 30 min. For competition
studies, the nuclear extracts were incubated with 1- or 10-
fold molar excess of unlabelled competitor oligonucle-
otides. For supershift analysis, the same amounts of
nuclear extracts were preincubated with 2 ml of either anti-
NRF-2 (sc-28311 X; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), anti-YY-1 (sc-1703 X; Santa Cruz), or
anti-NF-1 (sc-870 X; Santa Cruz) antibody at 15°C for 15
min prior to the binding of the probe. All the DNA-pro-
tein complexes were analyzed on native 6% (w/v) poly-
acrylamide gels in 0.5× TBE buffer (22.5 mM Tris-borate,
5 mM EDTA) at 5 mA for 7 to 12 h depending on the frag-
ment size. The gels were then transferred onto nylon
membranes, detected using streptavidin-HRP with a
chemiluminescent substrate, and visualized by exposure
to Kodak Biomax MR films.
Semi-quantitative reverse transcription polymerase chain 
reaction (RT-PCR)
Total RNAs were extracted from various cell lines using
TRIZOL reagent (Gibco Invitrogen) followed by DNase
(Ambion) treatment to eliminate potential genomic DNA
contamination. The quality and integrity of the RNAs
were examined by agarose gel electrophoresis. Comple-
mentary DNA (cDNA) was synthesized from 1 mg of total
RNA using oligo d(T)-anchor primer (Roche Molecular
Biochemicals, Indianapolis, IN, USA) and M-MLV reverse
transcriptase (Ambion) according to the manufacturer's
instructions. After a 2-h incubation at 42°C, the reaction
mixtures were heat inactivated at 70°C for 10 min and
then applied as templates to amplify cDNAs specific for
PREPL (amplified with the forward primer 5'-GCACGCT-
GATGGCCGCCTAACTAAA-3' and the reverse primer 5'-BMC Molecular Biology 2009, 10:67 http://www.biomedcentral.com/1471-2199/10/67
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CCGCGATGGCTTCCTTGAGTTTCT-3' at 1 cycle of 95°C
for 5 min; 35 cycles of 95°C for 30 sec, 64°C for 30 sec,
and 72°C for 30 sec; and then 1 cycle of 72°C for 10 min).
The  C2ORF34  gene was examined with the forward
primer (5'-CGCCGAGGGAATACTTTAAACCAG-3') and
reverse primer (5'-GGGCAGGACGAGCAACAAGCA-
GAGT-3') under following condition 1 cycle at 95°C for 5
min; 30 cycles at 95°C for 30 sec, 67.5°C for 30 sec, and
72°C for 30 sec; and 1 cycle at 72°C for 10 min. ACTB (b-
actin) serving as internal control was amplified using the
primer set 5'-GATGATGATATCGCCGCGCT-3' and 5'-
TGGGTCATCTTCTCGCGGTT-3' under the following con-
ditions: 1 cycle at 95°C for 5 min; 28 cycles at 95°C for 30
sec, 64°C for 30 sec, and 72°C for 30 sec; and then 1 cycle
at 72°C for 10 min.
Chromatin immunoprecipitation assay (ChIP)
The ChIP assays were performed using the EZ ChIP kit
(Upstate, Lake Placid, NY, USA) according to the manu-
facturer's instructions. For each assay, 3 × 107 cells from
each cell line were incubated with 1% formaldehyde fixa-
tion solution for 10 min at room temperature and then
quenched with glycine. The nuclei were fully resuspended
in 1 mL lysis buffer with 5 ml protease inhibitor cocktail
and 1 ml PMSF. The lysates were sonicated 3 times (15 min
max power, 30 sec on and 30 sec off) at 4°C using Biorup-
tor (Diagenode SA, Liège, Belgium). Following sonica-
tion, the chromatin fragments of 200~1,000 bp with a
major size of 500 bp were yielded. The sonicated chroma-
tin was pre-cleaned with protein G agarose beads with
gentle agitation at 4°C for 2 h followed by centrifugation
at 5,000 × g for 1 min. One-tenth volume of the sample
was diluted in a ChIP dilution buffer (1.67 mM Tris-HCl
pH 8.1, 167 mM NaCl, 1.1% Triton X-100, 0.01% sodium
deoxycholate, 1.2 mM EDTA) and stored at 4°C as the
input fraction; the remaining solutions were divided into
several aliquots and incubated with 5 mg each of specific
antibodies including anti-NRF-2 (sc-28311 X; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-YY-1 (sc-1703
X; Santa Cruze), anti-histone 3 (Upstate), and control rab-
bit anti-IgG (Upstate) antibodies. The protein-DNA-anti-
body complexes were incubated at 4°C for overnight with
gentle rotation and then immunoprecipitated by protein
G agarose slurry for 2 h at 4°C. The chromatin immune
complexes were washed sequentially with 1 mL of low-
salt buffer, high-salt buffer, LiCl buffer, and TE buffer
before being eluted twice with 100 ml of elution buffer
(1% SDS and 0.1 M NaHCO3). The cross-linked anti-
body-TF-DNA complexes were reversed by the addition of
8 ml of 5 M NaCl and heated at 65°C overnight. After
removal of RNA and protein by the treatments with RNase
A and proteinase K, the remnant DNA and input control
were purified using the EZ ChIP kit. The precipitated
DNAs were subjected to PCR in attempt to amplify the
NRF-2 and YY-1 binding elements under the following
conditions: 1 cycle of 95°C for 5 min; 40 cycles of 95°C
for 30 sec, 68°C for 30 sec, and 72°C for 20 sec; and 1
cycle of 72°C for 5 min with the forward primer (5'-
CGCGCTCTCCCCGAATT-3') and reverse primer (5'-
TTGGGTTCCTGGGTTCTTTAGTC-3'). The amplified frag-
ments were then resolved electrophoretically on a 2% (w/
v) agarose gel and verified by DNA sequencing.
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Verification of the newly identified PREPL splice variant. The genomic 
organization and transcribed mRNA of PREPL are illustrated in the upper 
panel, with each exon numbered in bold. The designed primers (indicated 
by arrows) for RT-PCR include the common forward primer (Exon 1a-F) 
derived from the alternative exon 1a of PREPL, and a set of reversed prim-
ers (Exons 4-R, 6-R, 8-R, 10-R, 13-R and 14-R) derived from exons 4, 6, 
8, 10, 13 and 14, respectively. Bottom left: the amplified PCR products 
were detected on a 1.5% (w/v) agarose gel confirming the presence of the 
identified PREPL splice variant. Bottom right: the nucleotide sequences of 
the primers.




CpG methylation pattern of the PREPL-C2ORF34 bidirectional gene 
pair in normal tissues. Upper panel: The GC content from position -
1,100 to +636 is calculated using Methprimer software with a 200-bp 
sliding window, and with a ratio of observed versus expected CpGs greater 
than 0.7 with an average GC content larger than 60%. The identified 
322-bp CpG island (from position -286 to -607) is indicated in light blue. 
Lower panel: The bisulfite-treated genomic DNAs from human normal 
brain, colon, and testis tissues were PCR-amplified and then cloned into 
pGEM-T vector for autosequencing. A total of 4 clones were selected and 
the methylation patterns were analyzed and presented. Each row indicates 
an individual sequencing clone and each vertical line represents the same 
CpG position. The empty circles denote the unmethylated CpG sites, and 
the filled circles indicate the methylated CpG sites.
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Semi-quantitative PCR products from DNA prepared by ChIP assays. 
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